ArticleScientific reports2024

First-line chemotherapy with tislelizumab for patients with extensive-stage small cell lung cancer: a cost-effectiveness analysis.

Rong Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.